8-K

UNITEDSTATES

SECURITIESAND EXCHANGE COMMISSION

Washington,D.C. 20549

FORM8-K

CURRENTREPORT

Pursuantto Section 13 or 15(d)

ofThe Securities Exchange Act of 1934

Dateof Report (Date of earliest event reported): May 26, 2021

DOCUMENTSECURITY SYSTEMS, INC.

(Exactname of registrant as specified in its charter)

6Framark Drive

Victor,New York 14564

(Addressof principal executive offices) (Zip Code)

Registrant’stelephone number, including area code: (585) 325-3610

N/A

(Formername or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging growth company [  ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

Item3.02 Unregistered Sales of Equity Securities.

Document Security Systems, Inc. (“we,” “us,” and “our”) is filing this Current Report on Form 8-K (the “Form 8-K”) to reflect the issuance of 5,450,000 restricted shares of Common Stock on May 26, 2021 to Global BioMedical Pte. Ltd., pursuant to the conversion of 35,316 shares of the Series A Preferred Stock at a conversion price of $6.48 per share.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.